Floatz logo

Metformin

Cannabis Use

Nova Scotia Health AuthoritySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Cannabis Use cohort.

Asset / SponsorPhaseRating
Clozapine
Dartmouth-Hitchcock Medical Center
Phase 4BB
Risperdal
Dartmouth-Hitchcock Medical Center
Phase 4BB
Topamax
University of Cincinnati
Phase 4BB
Seroquel®
University of Cincinnati
Phase 4BB
Tirzepatide
McMaster University
Phase 3B

View all 15 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →